LoginRegister
    Dr Reddys gets 8 USFDA observations for Duvvada facility in Andhra PradeshDr Reddys gets 8 USFDA observations for Duvvada facility in Andhra Pradesh
    Alembic Pharma clears USFDA inspection at Bioequivalence facility in VadodaraAlembic Pharma clears USFDA inspection at Bioequivalence facility in Vadodara
    Dr Reddys launches generic version of Sabril powder in US to treat epilepsyDr Reddy's launches generic version of Sabril powder in US to treat epilepsy
    Teva Pharma unveils generic version of EpiPen for children at USD 300 for 2 packsTeva Pharma unveils generic version of EpiPen for children at USD 300 for 2 packs
    Bayer sells Animal Health unit to US drug firm Elanco for USD 7.6 billionBayer sells Animal Health unit to US drug firm Elanco for USD 7.6 billion
    Much anticipated Medanta-Manipal deal comes to halt: ReportMuch anticipated Medanta-Manipal deal comes to halt: Report
    Dr Reddys unveils VERSAVO, biosimilar to Roche Avastin to treat types of cancers in IndiaDr Reddy's unveils VERSAVO, biosimilar to Roche Avastin to treat types of cancers in India
    Glenmark wins regulatory nod to market diabetes drug under brand names Remo-M, Remozen-M in IndiaGlenmark wins regulatory nod to market diabetes drug under brand names Remo-M, Remozen-M in India
    Boston Scientific gets USFDA approval for ImageReady MRI labelling for Vercise Gevia DBS SystemBoston Scientific gets USFDA approval for ImageReady MRI labelling for Vercise Gevia DBS System
    Sarepta Therapeutic fails to win USFDA approval for second Duchenne treatment GolodirsenSarepta Therapeutic fails to win USFDA approval for second Duchenne treatment Golodirsen
    Roche names Eli Lilly executive Levi Garraway as chief medical officerRoche names Eli Lilly executive Levi Garraway as chief medical officer
    Corruption: CDSCO Dty Drug controller arrested by CBI , suspended by Health MinistryCorruption: CDSCO Dty Drug controller arrested by CBI , suspended by Health Ministry
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X